Asset Details
Do you wish to reserve the book?
Recent advances in the noninvasive diagnosis of renal osteodystrophy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Recent advances in the noninvasive diagnosis of renal osteodystrophy
Do you wish to request the book?
Recent advances in the noninvasive diagnosis of renal osteodystrophy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Recent advances in the noninvasive diagnosis of renal osteodystrophy
2013
Overview
Chronic kidney disease–mineral and bone disorder (CKD-MBD) is the term used to describe a constellation of biochemical abnormalities, bone disturbances that may lead to fractures, and extraskeletal calcification in soft tissues and arteries seen in CKD. This review focuses on the noninvasive diagnosis of renal osteodystrophy, the term used exclusively to define the bone pathology associated with CKD. Transiliac bone biopsy and histomorphometry with double-labeled tetracycline or its derivatives remains the gold standard for diagnosis of renal osteodystrophy. However, histomorphometry provides a ‘window’ into bone only at a single point in time, and is not clinically practical for studying continuous changes in bone morphology. Furthermore, the etiology of fractures in CKD is multifactorial and not fully explained by histomorphometry findings alone. The propensity of a bone to fracture is determined by bone strength, which is affected by bone mass and bone quality; the latter is a term used to describe the structure and composition of bone. Bone quantity is traditionally assessed by dual X-ray absorptiometry (DXA) and CT-based methods. Bone quality is more difficult to assess noninvasively, but newer techniques are emerging and are described in this review. Ultimately, the optimal diagnostic strategy for renal osteodystrophy may be a combination of multiple imaging techniques and biomarkers that are specific to each gender and race in CKD, with a goal of predicting fracture risk and optimizing therapy.
Publisher
Elsevier Inc,Elsevier Limited
Subject
/ Arteries
/ Biopsy
/ Bone and Bones - diagnostic imaging
/ Chronic Kidney Disease-Mineral and Bone Disorder - blood
/ Chronic Kidney Disease-Mineral and Bone Disorder - complications
/ Chronic Kidney Disease-Mineral and Bone Disorder - diagnosis
/ Chronic Kidney Disease-Mineral and Bone Disorder - diagnostic imaging
/ Chronic Kidney Disease-Mineral and Bone Disorder - pathology
/ CKD-MBD
/ Diagnostic Imaging - methods
/ Humans
We currently cannot retrieve any items related to this title. Kindly check back at a later time.